Clinical Trials Sponsored by Prophylix Pharma AS

Total 17 results

Chemi-Pharm AS

Recruiting

The Efficacy and Safety of BioBlock® Intranasally Administered Virus-Neutralizing Bovine Colostrum Nasal Spray in Preventing of COVID-19 (Coronavirus Disease-19) Infection in Healthy Volunteer Individuals

SARS CoV 2 Infection

Estonia
BDD Pharma Ltd
AlgiPharma AS

Completed

A Study to Investigate Lung Deposition of Radiolabelled OligoG

Cystic Fibrosis

United Kingdom
Apokus AS
Norwegian Pharmacy Association

Recruiting

Effects of Medisinstart for Type 2 Diabetes

Type 2 Diabetes

Norway
Apokus AS
Norwegian Pharmacy Association

Completed

Effectiveness of "Medisinstart"

Cardiovascular Diseases

Norway
Prophylix Pharma AS
Larix A/S; Fraunhofer Institute for Molecular Biology and Applied Ecology; Deutsches... and other collaborators

Completed

Kinetics of Blood Platelets Transfused to Healthy Subjects

Fetal and Neonatal Alloimmune Thrombocytopenia

Germany
AdjuTec Pharma AS
CTC Clinical Trial Consultants AB

Not yet recruiting

A First-in-human Trial to Evaluate Safety, Tolerability, and Pharmacokinetics of APC148 in Healthy Adults

Healthy Subjects

Sweden
Pharma Holdings AS
University Hospital of North Norway

Completed

LTX-109 as Treatment for Hidradenitis Suppurativa

Hidradenitis Suppurativa

Norway
Pharma Holdings AS
CTC Clinical Trial Consultants AB

Recruiting

Study to Evaluate a Single Dose of LTX-109 in Subjects With COVID-19 (Coronavirus Disease 2019) Infection.

COVID-19

Sweden
Nykode Therapeutics ASA
Roche Pharma AG; Vaccibody AS

Completed

Investigating the Combination of VB10.16 and Atezolizumab in Patients With HPV 16-positive Cervical Cancer

Cervical Cancer | Cervix Cancer

Belgium, Germany, Bulgaria, Czechia, Norway, Poland
Pharma Holdings AS
CTC Clinical Trial Consultants AB

Completed

Study to Evaluate the Efficacy, Safety and Tolerability of 3% LTX-109 for Nasal Decolonisation of Staphylococcus Aureus

Nasal Decolonization of Staphylococcus Aureus

Sweden
Pharma Holdings AS
CTC Clinical Trial Consultants AB

Completed

A Study to Evaluate the Safety and Efficacy of 3% LTX-109 for Nasal Decolonisation of Staphylococcus

Nasal Decolonization of Staphylococcus Aureus

Sweden
Allarity Therapeutics
Smerud Medical Research International AS; Lantern Pharma Inc.

Active, not recruiting

Irofulven in AR-targeted and Docetaxel-Pretreated mCRPC Patients With Drug Response Predictor (DRP®)

Metastatic Castration-Resistant Prostate Cancer Patients

Denmark
Biosergen AS
Nucleus Network Ltd; Select Pharma Pty Ltd; Greenlight Clinical

Recruiting

A Study to Assess the Safety, Tolerability and Pharmacokinetics of BSG005.

Invasive Fungal Infections

Australia
BioNumerik Pharmaceuticals, Inc.
Lantern Pharma Inc. became Sponsor of Tavocept (BNP7787) IND 051014 as of...

Completed

Evaluation of BNP7787 for the Prevention of Neurotoxicity in Metastatic Breast Cancer Patients Receiving Weekly Paclitaxel

Breast Neoplasms | Breast Diseases | Metastases, Neoplasm
BioNumerik Pharmaceuticals, Inc.
Lantern Pharma Inc. became Sponsor of Tavocept (BNP7787) IND 051014 as of...

Completed

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

Non-small Cell Lung Cancer

Poland, Russian Federation, Bulgaria, United States, Romania, Ukraine
Espen A. Haavardsholm
Oslo University Hospital; Pfizer; Roche Pharma AG; The Research Council of Norway; The Norwegian Rheumatism Association and other collaborators

Completed

Aiming for Remission in Rheumatoid Arthritis (RA) - the ARCTIC Trial (ARCTIC)

Rheumatoid Arthritis

Norway
Hans Törnblom
Karolinska University Hospital; Oslo University Hospital; Sahlgrenska University... and other collaborators

Completed

Mesalazine Treatment in IBS (The MIBS Study) (MIBS)

Irritable Bowel Syndrome

Sweden

Clinical Trials Sponsored by Prophylix Pharma AS

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Turkmenistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations